ReviewInternational journal of molecular sciences2023

Biomarkers for Monitoring Treatment Response of Omalizumab in Patients with Chronic Urticaria.

Nadja Højgaard Pedersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.